SCHEMBL5695322

SCHEMBL5695322

Cc1ccc(S(=O)(=O)n2cc(C)c(=O)[nH]c2=O)cc1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.75
CA2 P00918 2/20 0.75
POLB P06746 4/20 0.50
LMNA P02545 2/20 0.48
CRBN Q96SW2 1/20 0.47
KMT2A Q03164 1/20 0.46
MMP2 P08253 1/20 0.45
PKM P14618 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
MAPT P10636 2/20 0.43
RAPGEF4 Q8WZA2 1/20 0.43
RECQL P46063 1/20 0.43
KDM4E B2RXH2 1/20 0.42
UBE2N P61088 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
HTT P42858 2/20 0.41
ALDH1A1 P00352 1/20 0.41
ALDH3A1 P30838 1/20 0.41
NOD1 Q9Y239 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8559503 0.86 CA1 (1.00) CA1CA2POLBLMNAKMT2A
SCHEMBL7013629 0.86 CA1 (0.69) CA1CA2POLBLMNAKMT2A
SCHEMBL8561394 0.86 CA1 (0.69) CA1CA2POLBLMNACRBN
SCHEMBL16865327 0.77 CA1 (0.58) CA1CA2POLBLMNAMMP2
SCHEMBL7021931 0.77 CA1 (0.57) CA1CA2POLBCRBNMMP2
SCHEMBL13736277 0.75 CA1 (0.44) CA1CA2POLBLMNAALDH1A1
SCHEMBL8471820 0.75 CA1 (0.46) CA1CA2POLBLMNACRBN
SCHEMBL9684862 0.70 CA1 (0.52) CA1CA2POLBKMT2AMMP2
SCHEMBL11813074 0.70 POLB (0.70) CA1CA2POLBLMNAALDH1A1
SCHEMBL11817179 0.70 POLB (0.64) CA1CA2POLBLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0949250-A1 Process for manufacturing alpha1L-adrenoceptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1999-10-13 EP claimed
EP-0949250-B1 Process for manufacturing alpha1L-adrenoceptor antagonists HOFFMANN LA ROCHE (CH) 2006-05-03 EP disclosed
US-6156894-A INTERMEDIATES HOFFMAN-LA ROCHE INC. (US) 2000-12-05 US disclosed
EP-0949250-A1 Process for manufacturing alpha1L-adrenoceptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1999-10-13 EP disclosed